LIVI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.496
EU - Europa 16.384
AS - Asia 13.096
SA - Sud America 1.699
AF - Africa 340
OC - Oceania 200
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 2
Totale 59.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.163
RU - Federazione Russa 6.184
SG - Singapore 3.772
CN - Cina 3.387
PL - Polonia 2.773
IT - Italia 2.184
HK - Hong Kong 1.920
BR - Brasile 1.367
IE - Irlanda 1.316
VN - Vietnam 1.233
KR - Corea 1.112
SE - Svezia 1.103
FR - Francia 674
DE - Germania 644
FI - Finlandia 469
IN - India 426
GB - Regno Unito 359
JO - Giordania 252
UA - Ucraina 202
AU - Australia 195
CA - Canada 184
BD - Bangladesh 177
ID - Indonesia 147
JP - Giappone 141
AR - Argentina 123
ES - Italia 123
TR - Turchia 95
NL - Olanda 90
IQ - Iraq 84
MX - Messico 77
CH - Svizzera 76
CI - Costa d'Avorio 61
ZA - Sudafrica 55
EC - Ecuador 52
NG - Nigeria 52
PK - Pakistan 46
MA - Marocco 40
BE - Belgio 38
VE - Venezuela 38
CO - Colombia 32
CZ - Repubblica Ceca 31
SA - Arabia Saudita 29
UZ - Uzbekistan 29
EG - Egitto 26
PH - Filippine 26
AE - Emirati Arabi Uniti 25
CL - Cile 22
PE - Perù 22
TN - Tunisia 22
KE - Kenya 21
AZ - Azerbaigian 20
IL - Israele 20
KZ - Kazakistan 20
PY - Paraguay 20
LT - Lituania 19
DZ - Algeria 16
DO - Repubblica Dominicana 15
NP - Nepal 15
TH - Thailandia 15
HU - Ungheria 14
IR - Iran 14
AT - Austria 13
UY - Uruguay 13
BG - Bulgaria 11
BJ - Benin 10
PT - Portogallo 10
SC - Seychelles 10
CR - Costa Rica 9
GR - Grecia 9
KG - Kirghizistan 9
LB - Libano 9
MY - Malesia 9
BO - Bolivia 8
PA - Panama 8
SN - Senegal 8
TW - Taiwan 8
NI - Nicaragua 7
OM - Oman 7
AL - Albania 6
BH - Bahrain 6
HN - Honduras 6
JM - Giamaica 6
RO - Romania 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
MM - Myanmar 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
SV - El Salvador 5
DK - Danimarca 4
EU - Europa 4
GE - Georgia 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
BW - Botswana 3
CY - Cipro 3
DM - Dominica 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
Totale 59.167
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.319
Ashburn 3.397
Warsaw 2.754
Singapore 2.705
Fairfield 2.459
Hong Kong 1.629
Chandler 1.358
Dublin 1.313
Woodbridge 1.125
Seoul 1.099
Seattle 1.073
San Jose 991
Cambridge 974
Houston 946
Wilmington 799
Hefei 711
Beijing 685
Florence 463
Lawrence 443
Altamura 420
Ann Arbor 413
Buffalo 410
Ho Chi Minh City 388
Los Angeles 377
Princeton 359
Lauterbourg 320
The Dalles 309
Munich 293
Hanoi 282
Jacksonville 282
New York 260
Moscow 252
Paris 238
Boston 224
Mumbai 196
Council Bluffs 191
Shanghai 189
Melbourne 183
Helsinki 174
Medford 160
Dearborn 155
Kent 151
San Diego 142
Boardman 141
São Paulo 136
Dallas 131
Tokyo 124
Clifton 118
Milan 107
Frankfurt am Main 87
Jakarta 86
London 81
Rome 76
Orem 75
Turku 73
Redondo Beach 72
Guangzhou 68
Abidjan 61
Bern 61
Toronto 59
Falls Church 57
Barcelona 56
Chicago 55
Da Nang 51
Chennai 48
Brooklyn 46
Phoenix 46
Izmir 45
Abuja 44
Norwalk 44
Dong Ket 43
Montreal 43
Denver 42
Bengaluru 39
Stockholm 39
Tianjin 37
Belo Horizonte 36
Brussels 36
San Francisco 36
Baghdad 34
Haiphong 33
Lappeenranta 33
Hillsboro 32
Yubileyny 32
Johannesburg 31
Rio de Janeiro 31
Atlanta 30
Shenzhen 30
Pune 29
Tashkent 28
Andover 27
West Jordan 27
Biên Hòa 26
Brasília 25
Poplar 24
Redwood City 24
Amman 23
Bologna 23
Manchester 23
Naples 22
Totale 39.597
Salva come PNG Salva come JPEG
Nome #
Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study 358
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study 347
Quality of Life and Sexual Health in the Aging of PCa Survivors. 324
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 322
Raccomandazioni cliniche per il carcinoma mammario 315
Head and neck reconstruction with pedicled flaps in the free flap era. 311
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 304
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 304
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 295
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 291
Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study 289
A multiparametric method to assess the MIM deformable image registration algorithm 283
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 278
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 268
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 259
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 257
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 257
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 256
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 255
Operator-dependent reproducibility of size measurements of small phantoms and lung nodules examined with low dose thin-section 252
Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases. 252
Radiosensitivity in the breast cancer management scenario: Another step forward? 246
In Regard to Vaidya et al 243
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 241
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 240
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 239
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 238
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 238
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 234
Prognosis of men with penile metastasis and malignant priapism: a systematic review. 233
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 231
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 230
ADAM: A breathing phantom for lung SBRT quality assurance 227
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 225
ADAM phantom to test 4D medical imaging and dose delivery devices 224
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 222
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 220
Cervicoisthmic choriocarcinoma mimicking cesarean section scar ectopic pregnancy 218
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 218
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 218
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 215
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 215
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 214
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 211
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer. 210
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 210
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 210
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 210
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 209
Auto-planning for VMAT accelerated partial breast irradiation 209
A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix 207
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 207
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 207
Breast cancer in the elderly: treatment of 1500 patients. 206
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 206
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 206
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 206
Influence of age and subtype in outcome of operable liposarcoma 206
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. 205
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 204
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 203
Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study 203
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 202
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 202
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. 200
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 199
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 198
Interim PET after Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 198
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 195
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 195
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 193
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 193
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 192
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 191
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 191
Radiotherapy in the age of cancer immunology: Current concepts and future developments 190
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 190
Use of tamoxifen in pT1a-pT1b, pN0 breast cancer. 190
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 190
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 189
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 188
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 188
Role of core needle biopsy in primary breast lymphoma 187
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 187
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 187
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 186
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 185
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 185
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 184
Uterine sarcoma: twenty-seven years of experience. 184
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 184
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 184
Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients. 184
Accelerated Partial Breast Irradiation: Florence Phase 3 Trial Experience and Future Perspectives 183
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 183
Cancer stem cells: biology and potential therapeutic applications 182
A semi-automatic planning technique for whole breast irradiation with tangential IMRT fields 181
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 181
Automated planning through robust templates and multicriterial optimization for lung VMAT SBRT of lung lesions 181
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 181
Totale 22.224
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021417 0 0 0 0 0 0 0 0 0 0 233 184
2021/20222.233 58 175 189 130 71 111 83 198 98 111 390 619
2022/20236.166 565 1.252 262 348 451 1.051 775 414 685 63 170 130
2023/20242.592 109 252 368 137 166 365 116 581 53 134 206 105
2024/202517.072 623 1.685 1.048 2.739 4.892 1.977 304 985 824 534 632 829
2025/202618.110 2.095 2.581 1.747 1.687 2.271 729 2.500 1.043 1.322 1.415 720 0
Totale 59.718